Experimental re-evaluation of flunarizine as add-on antiepileptic therapy

Journal of Pharmacy and Bioallied Sciences

Volumn 3, Issue 2, 2011, Pages 253-258

  Thakur, Anamika ^a   Sahai, A ^a   Thakur, J ^a  

^a INDIRA GANDHI MEDICAL COLLEGE   (India)

Author keywords

Flunarizine; lamotrigine; PTZ; seizure; sodium valproate

Indexed keywords

FLUNARIZINE; LAMOTRIGINE; PENTETRAZOLE; VALPROIC ACID;

ADD ON THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SEIZURE; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ANIMALIA; MUS;

EID: 79957566168     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.80782     Document Type: Article

References (39)

1. Schwartzkroin PA, Wyler AR. Mechanisms underlying epileptiform burst discharge. Ann Neurol 1980;7:95-107. (Pubitemid 10156240)
2. Prince DA. Physiological mechanism of focal epileptogenesis. Epilepsia 1985;26:S3-14.
3. Meyer FB, Anderson RE, Sundt TM Jr. Anticonvulsant effects of dihydropyridine Ca2+ antagonists in electrocortical shock seizures. Epilepsia 1990;31:68-74. (Pubitemid 20061089)
4. Stafstrom CE. Mechanisms of action of antiepileptic drugs: The search for synergy. Curr Opin Neurol 2010;23:157-63.
5. Desai CK, Dikshit RK, Mansuri SM, Shah UH. Comparative evaluation of anticonvulsant activity of calcium channel blockers in experimental animals. Indian J Exp Biol 1995;33:931-4.
6. Vizzani A, Wu HQ, Stasi MA, Angelico P, Samanin R. Effect of various calcium channel blockers on three different models of limbic seizures in rats. Neuropharmacology 1988;27:451-8.
7. Czuczwar SJ, Gasior M, Janusz W, Kleinrok Z. Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology 1992;31:1179-83.
8. Gasior M, Kaminski R, Brudniak T, Kleinrok Z, Czuczwar SJ. Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazole in mice. J Neural Transm 1996;103:819-31. (Pubitemid 26383658)
9. Sobaniec W, Kulak W. Influence of flunarizine and clobazam on the electrically induced seizures in rats. Neurosci Jpn 1990;16:541-6.
10. De Sarro GB, Meldrum BS, Nistico G. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br J Pharmacol 1988;93:247-56. (Pubitemid 18042810)
11. Luszczki JJ, Trojnar MK, Trojnar MP, Kimber-Trojnar Z, Szostakiewicz B, Zadrozniak A, et al. Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model. Pharmacol Rep 2007;59:672-82. (Pubitemid 351586558)
12. Luszczki JJ, Trojnar MK, Trojnar MP, Kimber-Trojnar Z, Szostakiewicz B, Zadrozniak A, et al. Effects of amlodipine, diltiazem, and verapamil on the anticonvulsant action of topiramate against maximal electroshock-induced seizures in mice. Can J Physiol Pharmacol 2008;86:113-21. (Pubitemid 351536460)
13. Kaminski RM, Mazurek M, Turski WA, Kleinrok Z, Czuczwar SJ. Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures. Pharmacol Biochem Behav 2001;68:661-8. (Pubitemid 32411603)
14. Shantilal P, David J, Joseph T. Effects of sodium valproate and flunarizine administered alone and in combination on pentylenetetrazole model of absence seizures in rat. Indian J Exp Biol 1999;37:228-33. (Pubitemid 29128034)
15. Joseph S, David J, Joseph T. Synergistic effect of flunarizine and sodium valproate on seizure thresholds elicited by cortical stimulation in conscious rats. Indian J Physiol Pharmacol 1998;42:39-49. (Pubitemid 28293354)
16. Subramanyam K, David J, Joseph T. Interaction of flunarizine with sodium valproate or ethosuximide in gamahydroxybutyrate induced absence seizures in rats. Indian J Exp Biol 2001;39:998-01.
17. Jaishree J, Kumaresan S, Sudha S, David J, Kulkarni C. Individual and combined effects of N6-cyclopentyladenosine, flunarizine and diazepam on aminophylline-induced recurrent generalized seizures in mice. Pol J Pharmacol 2003;55:559-64. (Pubitemid 37185359)
18. Fischer W, Kittner H, Regenthal R, De Sarro G. Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects. Basic Clin Pharmacol Toxicol 2004;94:79-88.
19. Kułak W, Sobaniec W, Wojtal K, Czuczwar SJ. Calcium modulation in epilepsy. Pol J Pharmacol 2004;56:29-41. (Pubitemid 38515283)
20. Overweg J, Binnie CD, Meijer JW, Meinardi H, Nuijten ST, Schmaltz S, et al. Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy. Epilepsia 1984;25:217-22. (Pubitemid 14108968)
21. Moglia A, Bergamasco B, Di Perri R, Mancia D. Flunarizine as addon therapy in epilepsy. Crossover study vs placebo. Funct Neurol 1986;1:547-50.
22. Fröscher W, Bülau P, Burr W, Penin H, Rao ML, de Beukelaar F. Double-blind placebo-controlled trial with flunarizine in therapy-resistant epileptic patients. Clin Neuropharmacol 1988;11:232-40.
23. Starreveld E, de Beukelaar F, Wilson AF, McLean DR, Findlay HP. Double-blind cross-over placebo controlled study of flunarizine in patients with therapy resistant epilepsy. Can J Neurol Sci 1989;16:187-90. (Pubitemid 19161245)
24. Alving J, Kristensen O, Tsiropoulos I, Mondrup K. Double-blind placebo-controlled evaluation of flunarizine as adjunct therapy in epilepsy with complex partial seizures. Acta Neurol Scand 1989;79:128-32. (Pubitemid 19059883)
25. Chaisewikul R, Baillie N, Marson AG. Calcium antagonists as an add-on therapy for drug-resistant epilepsy. Cochrane Database Syst Rev 2001;4:CD002750.
26. Holmes GL. Animal model studies application to human patients. Neurology 2007;69:S28-32.
27. Giorgi O, Orlandi M, Lecca D, Corda MG. MK- 801 prevents chemical kindling induced by pentylenetetrazole in rats. Eur J Pharmacol 1991;193:363-5.
28. Kwan P, Brodie MJ. Definition of refractory epilepsy: Defining the indefinable? Lancet Neurol 2010;9:27-9.
29. th ed. New York: Macmillan; 2006. p. 501-26.
30. Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS. Flunarizine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 1984;27:6-44. (Pubitemid 14209392)
31. Rogawski MA, Porter RJ. Antiepileptic drugs: Pharmacological mechanisms efficacy with consideration of promising developmental stage compounds. Pharmaol Rev 1990;42:223-86. (Pubitemid 20291784)
32. van Luijtelaar EL, Ates N, van der Staay FJ. The effects of chronic treatment with a calcium channel antagonist on two types of generalized epilepsies in rats. Pharmacol Biochem Behav 1994;48:575-9. (Pubitemid 24216992)
33. Binnie CD, de Beukelaar F, Meijer JW, Meinardi H, Overweg J, Wauquier A, et al. Open dose-ranging trial of flunarizine as add-on therapy in epilepsy. Epilepsia 1985;26:424-8. (Pubitemid 16226440)
34. Grabenstatter HL, Ferraro DJ, Williams PA, Chapman PL, Dudek FE. Use of chronic epilepsy models in antiepileptic drug discovery: The effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 2005;46:8-14. (Pubitemid 40179927)
35. van Vliet EA, Edelbroek PM, Gorter JA. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats. Epilepsia 2010;51:362-70.
36. Kasperaviciute D, Sisodiya SM. Epilepsy pharmacogenetics. Pharmacogenomics 2009;10:817-36.
37. Sabers A, Gram L. Drug treatment of epilepsy in the 1990s-achievements and new developments. Drugs 1996;52:483-93. (Pubitemid 26340532)
38. Kwan P, Brodie MJ. Combination therapy in epilepsy. When and what to use. Drugs 2006;66:1817-29.
39. Kwan P, Brodie MJ. Emerging drugs for epilepsy. Exp Opinion Emerg Drugs 2007;12:407-22. (Pubitemid 47518376)